Revenue | $100 - $500 million See Exact Annual Revenue |
---|---|
Employees | 10 - 100Exact Company Size |
Primary Industry | 325411 Medicinal & Botanical Manufacturing |
Additional NAICS Codes | 325412 Pharmaceutical Preparation Manufacturing |
Address | 6550 Dumbarton Cir Ste A Fremont, CA 94555 |
Alexza Pharmaceuticals | Revenue Est. ($ Million) | Growth Rate (%) | # Employees |
---|---|---|---|
2023 | $100 - $500 million Details in Premium Report | ||
2022 | |||
2021 | |||
2020 | |||
2019 |
1-Year Growth Rate: 3-Year Growth Rate (CAGR): |
Alexza Pharmaceuticals P&L | $ Millions |
---|---|
Revenue (Sales) | |
Cost of Goods Sold | |
Gross Profit | |
Operating Expenses | |
Advertising | |
Salaries and wages | |
Other Operating Expenses | |
Total Operating Expenses | |
Operating Income | |
EBITDA | |
EBIT (Earnings Before Interest and Taxes) | |
Net Profit | |
Trademark | Date |
---|---|
OBT Pharmaceutical preparations for the diagnosis and treatment of psychiatric disorders, neurological disorders, and gastrointestinal disorders, and analgesics; pharmaceutical delivery devices in the nature of inhalers filled with drugs and diagnostic preparations for the detection and treatment of psychiatric disorders, neurological disorders, gastrointestinal disorders, and pain | 06/03/2019 |
ONE BREATH TECHNOLOGY Pharmaceutical preparations for the diagnosis and treatment of psychiatric disorders, neurological disorders, and gastrointestinal disorders, and analgesics; pharmaceutical delivery devices in the nature of inhalers filled with drugs and diagnostic preparations for the detection and treatment of psychiatric disorders, neurological disorders, gastrointestinal disorders, and pain | 09/01/2017 |
ENGAGE THERAPEUTICS Pharmaceutical preparations for the diagnosis and treatment of psychiatric disorders, neurological disorders, gastrointestinal disorders, and central nervous system disorders; pharmaceutical delivery devices in the nature of inhalers filled with drugs and diagnostic preparations for the detection and treatment of psychiatric disorders, neurological disorders, gastrointestinal disorders, and central nervous system disorders | 04/06/2015 |
Company | Headquarters | Revenue ($ MM) |
---|---|---|
XYMOGEN | Orlando, FL | 100 |
AVANTI NUTRITIONAL LABORATORIES | Miami Lakes, FL | 37 |
NUTRITION FORMULATORS | Miramar, FL | 36 |
RTPR | Cabot, AR | 33 |
INTEGRATED BOTANICS | Fort Worth, TX | 29 |
COSMAX NBT USA | Garland, TX | 29 |
CJB INDUSTRIES | Valdosta, GA | 28 |
ALTERNATIVE LABORATORIES | Naples, FL | 28 |
S&B PHARMA | Azusa, CA | 28 |
Company | Headquarters | Revenue ($ MM) |
---|---|---|
IMPAX LABORATORIES | Hayward, CA | 100 |
SIGHTGLASS MGMT | Alameda, CA | 84 |
ASTEX PHARMACEUTICALS | Pleasanton, CA | 25 |
INTUITY MEDICAL | Fremont, CA | 25 |
ALEXZA PHARMACEUTICALS | Fremont, CA | 19 |
VECTOR LABORATORIES | Newark, CA | 15 |
Company | Revenue ($ MM) |
---|---|
|